Brief: McKesson Q2 Adjusted EPS USD 9.86 Vs. IBES Estimate USD 9.02
Nov 05 (Reuters) - McKesson Q2 revenue USD 103,150 million vs. IBES estimate USD 104,186 million. Q2 adjusted net income USD 1,227 million vs. IBES estimate USD 1,119 million Q2 EPS USD 8.92 outlook FY adjusted EPS USD 38.35-38.85
Recent news on McKesson
See all newsMedia: McKesson's medical unit prices $2.25 billion leveraged loan ahead of IPO- Bloomberg News
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson
McKesson expects 2027 profit slightly above estimates on drug distribution strength
McKesson beats Q4 profit estimates, maintains long-term profit growth forecast
Brief: McKesson Q4 Adjusted EPS USD 11.69 Vs. IBES Estimate USD 11.6